KDR and cancer: In recent years, to develop therapeutic modalities for preventing angiogenesis in some illnesses such as different types of cancers, ophthalmic sicknesses and inflammation-related diseases, VEGF/VEGFR2 signaling is perhaps the most extensively studied and successfully targeted [31].